Pascale Cony-Makhoul

Pascale Cony-Makhoul

UNVERIFIED PROFILE

Are you Pascale Cony-Makhoul?   Register this Author

Register author
Pascale Cony-Makhoul

Pascale Cony-Makhoul

Publications by authors named "Pascale Cony-Makhoul"

Are you Pascale Cony-Makhoul?   Register this Author

40Publications

1537Reads

10Profile Views

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Leukemia 2019 09 9;33(9):2324-2330. Epub 2019 Apr 9.

ProfilExpert, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0452-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756025PMC
September 2019

Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.

Cancer Med 2019 06 30;8(6):3296-3304. Epub 2019 Apr 30.

B2PHI Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, UVSQ, Paris Saclay Univ, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558491PMC
June 2019

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

Early-onset hypogammaglobulinemia: A survey of 44 patients.

J Allergy Clin Immunol 2015 Oct 8;136(4):1097-9.e2. Epub 2015 May 8.

INSERM UMR 1163, Paris, France; Paris Descartes University - Sorbonne Paris Cité, Imagine Institute, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2015.03.038DOI Listing
October 2015

Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.

Br J Haematol 2014 Aug 18;166(3):390-400. Epub 2014 Apr 18.

Caen University Hospital, Laboratory of Haematology, Caen, France; University of Caen, Medical School, EA4652, Caen, France; Caen University Hospital, Regional Registry of Malignant Haemopathies of Lower-Normandy, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12908DOI Listing
August 2014

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

J Clin Oncol 2014 Feb 9;32(5):424-30. Epub 2013 Dec 9.

Philippe Rousselot, Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles; Aude Charbonnier, Institut Paoli Calmette, Marseille; Pascale Cony-Makhoul, Hôpital d'Annecy, Pringy; Philippe Agape, Hôpital Felix Guyon-Centre Hospitalier Universitaire en France (CHU) de la Réunion, La Réunion; Franck E. Nicolini, Centre Hospitalier Lyon Sud, Pierre-Bénite; Bruno Varet, Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes; Delphine Réa and Jean Michel Cayuela, Hôpital Saint-Louis, AP-HP, Paris; Martine Gardembas, CHU d'Angers, Angers; Gabriel Etienne and Josy Reiffers, Institut Bergonié; François-Xavier Mahon, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux; Lydia Roy, Joëlle Guilhot, and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM) Centres d'Investigation Clinique CHU de Poitiers, Poitiers; Martine Escoffre-Barbe, Centre Hospitalier Pontchaillou, Rennes; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Michel Tulliez, Hôpital Henri Mondor, AP-HP, Créteil; Stéphane Prost, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses; Marc Spentchian, Hôpital Mignot, Le Chesnay; and Jean Claude Chomel and Ali Turhan, INSERM U935, Université Poitiers et Paris Sud, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5797DOI Listing
February 2014

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Medicine (Baltimore) 2013 Sep;92(5):e1-e9

From the French Eosinophil Network-EA-2686 and Department of Immunology (FL, SM, DL, SD, LP, JEK); Laboratory of Hematology, INSERM U837-Institut de Recherche contre le Cancer (AR, CP); Department of Internal Medicine (PYH); and INSERM U995 (MC), CHRU de Lille, Université Lille-Nord de France, Lille; CNRS UMR 8147 and Department of Hematology (EM), Hôpital Necker-Enfants Malades Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-5 Descartes, Paris; Department of Internal Medicine (FA, OB, JEK), Hôpital Foch, Université Versailles Saint-Quentin en Yvelines, Suresnes; Laboratory of Hematology (JMC), Hôpital Saint-Louis (AP-HP), Université Paris-7 Diderot, Paris; Department of Hematology (PR), Hôpital André Mignot, Université Versailles Saint-Quentin en Yvelines, Le Chesnay; Department of Hematology (AST), CHU Angers, Angers; Department of Internal Medicine (OF), Hôpital Jean Verdier (AP-HP), Bondy; Department of Internal Medicine (MM), Hôpital Henri Mondor (AP-HP), Créteil; Department of Internal Medicine and Oncology (JPdJ), Hôpital d'Instruction des Armées Sainte-Anne, Toulon; Department of Hematology (PCM), Centre Hospitalier d'Annecy, Pringy; Department of Internal Medicine (DS), Hôpital Lariboisière (AP-HP), Paris; Department of Pneumology (VC), Hôpital Louis Pradel-Hospices Civils de Lyon, Lyon; Department of Internal Medicine A (MH), CHU Hotel-Dieu, Nantes; Department of Internal Medicine (OL), Hôpital Bichat-Claude Bernard (AP-HP), Paris; and Department of Pediatric Hematology (AB), Hôpital Robert Debré (AP-HP), Paris; France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3182a71ebaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553979PMC
September 2013

Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients.

Leuk Res 2011 Jan 29;35(1):38-43. Epub 2010 Jul 29.

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Laboratory for Molecular Biology and UMR5239 CNRS, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000322
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.06.030DOI Listing
January 2011

Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571.

Br J Haematol 2002 Oct;119(1):109-11

Laboratoire de Greffe de Moelle et Laboratoire d'hématologie, Université Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03708.xDOI Listing
October 2002

Imatinib mesylate and gray hair.

N Engl J Med 2002 Aug;347(6):446

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJM200208083470614DOI Listing
August 2002